References
- Iqbal J, Weisenburger DD, Greiner TC et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood115, 1026–1036 (2010).
- Feldman AL, Dogan A, Maurer MJ et al. Expression of interferon regulatory factor-4 (IRF4/MUM1) is associated with inferior overall survival in peripheral T-cell lymphoma. Blood116, 66 (2010) (Abstract 140).
- Hochberg J, Waxman IM, Kelly KM, Morris E, Cairo MS. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Br. J. Haematol.144, 24–40 (2009).
- Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol.26, 4124–4130 (2008).
- Yamamoto K, Utsunomiya A, Tobinai K et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J. Clin. Oncol.28, 1591–1598 (2010).
- Smith SM, Burns LJ, Van Besien K et al. Autologous (auto) versus allogeneic (allo) hematopoietic cell transplantation (HCT) for T-NHL: a CIBMTR analysis. Blood116, 303 (2010) (Abstract 689).
- Le Gouill S, Milpied N, Buzyn A et al. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J. Clin. Oncol.26, 2264–2271 (2008).
- Kyriakou C, Canals C, Finke J et al. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J. Clin. Oncol.27, 3951–3958 (2009).